Ultragenyx FDA-Approved Treatment Shows Sustained Reduction in Cornstarch Intake

기사 요약

Ultragenyx reports positive 96-week Phase 3 results for GENGLYCOS in GSDIa patients, showing sustained daily cornstarch reductions.